The effect of arachidonic acid (AA) combined with UVA irradiation was studied in a model system mimicking phototherapy PUVA (psoralen+UVA) ex vivo in vitro. The contribution of damage to the plasma membrane by PUVA was tested on human lymphocytes derived from healthy donors. The effect of arachidonic acid (AA) combined with UVA irradiation was compared with that of a psoralen photoadduct to AA added to the culture. The adduct, obtained photochemically and purified, was characterized by NMR and MS spectrometry as a cycloadduct of psoralen to the vinylene bond of the acid (AA<>PSO).
plasma membrane changes in a synergic way. Preliminary studies indicated that changes in the transmembrane potential of mitochondria paralleled the apoptosis when cells were treated by AA alone.
Our findings showed that UVA radiation of lymphocytes in the presence of arachidonic acid, as in the presence of psoralen, enhanced apoptosis of cells in a synergic manner. Thus, PUVA-induced apoptosis may proceed in part by a still undefined signaling pathway(s) triggered in lymphocyte membranes.
Ultraviolet radiation A (320-400 nm) in combination with photosensitizing agents is widely applied to treatment of patients with various skin disorders like psoriasis, vitiligo, and other skin manifested diseases (Pathak & Fitzpatrick, 1992) . UV lamps emitting narrow band of UVB radiation (290-320 nm) are also applied for psoriasis treatment (Gordon et al., 1999; Calzavara-Pinton, 1997) . In both therapies, UV radiation alone and PUVA (psoralen+UVA), successful treatment is presumably due to the deep penetration of UV rays into the skin, comprising subcutaneous peripheral blood capillaries furnished with leukocytes responsible for the immune balance of the system (Krutmann, 1998) . The therapeutic effects of PUVA applied systemically to patients with psoriasis apparently stem from its lethal effect on activated T cells infiltrating skin lesions (Coven et al., 1999) . Since the application of a modality of PUVA ex vivo in vitro, called extracorporeal photopheresis (ECP-PUVA), it has been revealed that PUVA treatment preferentially accelerates apoptosis of neoplastic T cell clones of blood (Enomoto et al., 1997; Berger et al., 2002; Bladon & Taylor, 2003) .
The intricate mechanism of PUVA action is still a matter of research. Initially, the primary PUVA target was thought to be nuclear DNA (Song & Tapley, 1979) , subsequently DNA and proteins of lymphocytes (Schmitt et al., 1995) , and recently, membrane lipids in skin cells and in skin infiltrating T cells (Zarębska et al., 2000) . Although numerous studies had been devoted to the mechanism of beneficial PUVA treatment, no straightforward correlation has been found between the photochemical damage of nuclear DNA inside the cell and the immune response reflected in apoptosis (Godar, 1999a) or the spectrum of cytokines released from the cells (Tokura et al., 2001) .
In a system mimicking the ECP-PUVA modality one can test in vitro the effects of UVA irradiation in combination with various photosensitizers on apoptosis induced in neoplastic leukocyte lines (Godar, 1999b) . In this report, normal human leukocytes originated from human blood (peripheral blood mononuclear cells, PBMC) were treated with UVA alone, and with UVA in combination with additives: psoralen, arachidonic acid or its psoralen photoadduct. For detectable effects, all the treatments applied to a primary PBMC culture were tested at doses exceeding those used in UVA/PUVA therapies (1 mM psoralen and 2-6 J/cm 2 of UVA). Cell viability and apoptosis were followed 20 h after treatment by means of flow cytometry with the aid of the following probes: annexin V tagged with fluorescein isothiocyanate (Anx-V), propidium iodide (PI), and JC-1 (5,5¢,6,6¢-tetrachloro-1,1¢,3,3¢-tetraethylbenzimidazolylcarbocyanine iodide). This approach enabled us to show that lymphocytes treated by UVA in the presence of arachidonic acid undergo apoptosis similar to that induced by classic PUVA (psoralen + UVA) in an epidermal cell line (Schindl et al., 1998) .
To test the contribution of plasma membrane damage, leukocytes were treated with exogeneous additives, with and without UVA radiation. Arachidonic acid (AA) was chosen as the most powerful agent among other fatty acids interacting with membrane lipids. When AA was added to rat lymphocytes at a concentration of 50 mM, it inhibited [ 3 H]thymidine incorporation more effectively than linoleic or saturated fatty acids (Calder et al., 1991) . At 75 mM AA tested in situ on a rat hepatoma cell line induced high reduction in mitochondrial membrane potential, and about twice higher reduction than linoleic acid in contrast to saturated fatty acids which were practically without effect (Bernardi et al., 2002, Fig. 4 ). Our previous investigations have shown that freshly isolated, short lived, psoralen fatty acid cyclobutane adducts activate: (1) protein kinase pathway in human platelets, (2) tyrosinase activity enhancing melanin production in human melanocytes in culture and (3) apoptosis in human lymphocytes in culture (Caffieri et al., 1996) . Cyclobutane adducts of 8-methoxypsoralen to unsaturated fatty acids were detected in the membrane fraction of human lymphocytes UVA irradiated in vitro (Caffieri et al., 1991) . In the present studies arachidonic acid psoralen cyclobutane adduct, AA<>PSO, served as a model compound of products formed in vivo during PUVA therapy. The aim of present studies was to investigate whether AA and its photoadduct induce apoptosis in cultured human lymphocytes.
The presented findings evidence that arachidonic acid and its cyclobutane adduct with psoralen take part in a still undefined signaling pathway(s) which induces apoptosis in human lymphocytes. The contribution of damage to lecithins or phospholipids in the PUVA induced apoptosis is discussed.
MATERIALS AND METHODS
Isolation and culture of primary human lymphocytes. Peripheral blood mononuclear cells were isolated from 40 ml of blood of thirteen healthy volunteers by a standard procedure. All volunteers gave their consent to venipuncture and testing of their blood sample. Blood withdrawn into heparin solution was centrifuged in a Gradisol gradient (Aqua Medica, Łódź, Poland), washed with phosphate-buffered saline (PBS), spun down and suspended in RPMI 1640 medium (Sigma-Aldrich) supplemented with 2 mM glutamine, 100 U/ml penicillin/streptomycin, 10 mM Hepes buffer, pH 7.4, and 5% fetal calf serum (BioCult). The cells were pelleted, suspended in medium at 10 6 cells/ml, and placed on a 24-well ELISA plate; each sample was supplemented with appropriate additives and filled up with medium to 1 ml. The culture was incubated at 37°C in a humidified atmosphere with 5% CO 2 for about 20 h. Then, the cultured PBMC were removed from the wells, and subsequently stained. After 30 min of incubation, the experimental wells were irradiated, with the adjacent control wells covered with aluminum foil. An Osram HQV125 lamp placed horizontally at a 3.5 cm distance from the plate was cooled in a stream of air from a fan, while the ELISA plate was shielded with a plastic cover and kept on ice to avoid excessive heating. The commercially characterized lamp emitted predominantly at 365.5 nm, with admixture of 6.6% at 334.2 nm and 3.3% at 313 nm. The irradiation intensity was 0.33 J/cm 2 per min as measured by an IL-1500 Radiometer with an SEE 015 UVA-sensitive probe (International Light, MA, U.S.A.). The plastic cover of ELISA plate transmits UV light above 290 nm, with 80% of transmittance at 365 nm and about 60% above 330 nm. Preparation of photoadduct. The photoadduct of arachidonic acid was obtained according to the procedures used to produce photoadducts of psoralen to lecithin (Zarębska et al., 1998) . Briefly, a mixture of AA and PSO at a molar ratio 8 : 1 was irradiated in ethanol with 30 J/cm 2 of UVA in a pyrex tube for 90 min with two HQV125 Osram lamps. After irradiation, the mixture was separated on TLC60 F254 plates (Merck) in hexane/ether/formic acid (50 : 50 : 2, by vol.). One of the 11 resultant spots, with R F 0.49, located above the psoralen control (R F 0.38) was eluted with ethanol, purified by millipore filtration (Millex FH13, Sigma). That spot, containing the adduct formed at the highest yield (about 4% of the initial psoralen concentration) was used for molecular characteristics and in the tests with lymphocytes. Subsequent NMR analysis was performed one day after chromatography, and MS within two weeks. The adduct remained stable when kept refrigerated in a dry state as checked by its absorption spectra. Spectroscopy analysis. Absorption spectra were recorded in ethanol on a Varian Cary 3E spectrophotometer (Australia). NMR analysis was performed with a Varian Unity Plus 500 MHz spectrometer (Varian, Palo Alto, CA, U.S.A.) using methods similar to those previously described . Linear and two-dimensional NMR spectra were measured by collecting 128 acquisitions for each spectrum, recorded at 25°C. The signal of the solvent CDCl 3 (Merck, 99.8%) was taken as internal reference at 7.31 p.p.m. Two-dimensional spectra, COSY (COrrelation SpectroscopY) were made with a resolution of 4096´512 for t 2 and t 1 , respectively; for TOCSY (TOtal Correlation SpectroscopY) the mixing time was 80 ms (Bax & Davis, 1985) . The accuracy of the measurements was ±0.01 p.p.m. for the chemical shifts, compared with the NMR spectra of original psoralen and arachidonic acid as controls.
Mass spectra were performed with Micromass Q-TOF (Quadruple Time of Flight, England) for two separate chromatographic isolates with R F 0.49. Control mass spectra were those of AA calculated at 305.248 (+1) and detected at 305.278, and of psoralen calculated at 187.039 (+1) and detected at 187.059 average m/z.
RESULTS

Studies with lymphocytes
The physiological response with regard to apoptosis and transmembrane potential of cells induced by various treatments are presented within Figs. 1-7, each set of results being obtained from a culture of the same donor, indicated in the legend. Analysis of cells derived from thirteen healthy donors gave similar results although with individual variance of donors' response as shown in Fig. 4 .
Leukocytes treated with any apoptogenic agent display a typical shift in cytofluorimetric density plots as shown in Fig. 1 (com- Vol. 52 Apoptosis induced by arachidonic acid in human lymphocytes 183 pare with data in Pompéia et al., 2002) . The gating circumscribed native and damaged cells and separated debris below 200 FSC-Height. The population of intact cells (Fig. 1A) was split into two subgroups (Fig. 1B) , where native cells (R2) were followed by cells undergoing apoptosis (R1), appearing as smaller and more granular ones. The cell populations of both subgroups R1 and R2 were further analyzed by Anx-V/PI bivariate flow cytometry differentiating into quadrants (panels C-F): untagged cells -still native; single positive, Anx-V + -early apoptotic, and double positive, Anx-V + PI + -late apoptotic cells. Left-hand panels of Fig. 1 -A, C, E -are of nontreated samples and righthand panels -B, D, F -are of samples treated with 100 mM of AA. The cell population of the right upper panels D and F (in comparison to panels C and E) discloses an increase of late apoptotic cells to about 15%, in the both subgroups, following treatment with 100 mM AA. However, the subgroup R2 disclosed more pronounced rearrangements of all panels.
The following figures present changes of apoptosis after various combinations of treatments. Figure 2 shows a dose dependent apoptotic shift after treatments with AA alone and its photochemical adduct with psoralen. Up to 100 mM AA added to the culture, the gradual decrease of cell viability ( Fig. 2A) was inversely related to the increase in the number of cells in gate 2 (Fig. 2B ). The dose dependent increase was due to incoming early and late apoptotic cells to the gated area. After 24 h of culture, the early apoptotic cells, Anx-V + , showed a small increment only up to 60 mM AA treatment and then a rapid decrease (Fig. 2C) . Increasing the dose of AA above 60-80 mM induced a shift towards late apoptotic cells, Anx-V + PI + , as shown in Fig.   2D . The adduct, AA<>PSO (dashed lines), induced apoptosis at a lower rate than native AA as shown in all panels in Fig. 2 . Apoptosis induction after adduct treatment was attained at concentrations 2-3 times higher than by arachidonic acid itself. This was confirmed by comparing 50% toxicity of the two agents towards lymphocytes for two other donors (MD, PD, not shown) which were treated with adduct up to 240 mM AA<>PSO. Notably, in Fig. 2 data for 100 mM AA<>PSO treatment, which was not tested with that donor, are missing.
Analysis of apoptosis induced by classic PUVA treatment, 1 mM of PSO plus increas- ing doses of UVA, is shown in Fig. 3 . The gradual decrease of cell viability with the increasing doses of UVA (2-6 J/cm 2 ) is shown in panel A. The increases in early apoptotic cells (panel B) were more pronounced than changes in the late apoptotic ones (panel C).
Evidently, UVA irradiation induced additional changes in the presence of psoralen which alone was inert as was checked in control samples. Notably, the changes induced by UVA alone were negligible (dashed lines) whereas those with the combined treatment (full lines) were significant which indicated a synergic action of psoralen and UVA radiation. In analogy, experiments combining AA and UVA treatment were performed (Fig. 4) . In panel A of Fig. 4 the viability curves declined faster under combined treatment of (AA+UVA) than those with AA alone; addition of 1 mM PSO accelerated cell death. The effect of combined treatments was always stronger than the sum of effects of separate treatments as was checked by appropriate controls. This was shown in the late apoptosis appearance (Fig. 4B) where UVA radiation significantly enhanced the action of AA alone, and an additional increment occurred when PSO and AA were both present in the culture. The accelerated toxicity of AA under UVA radiation and about doubled effect in the presence of PSO indicated synergy of actions.
The inverse shape of curves representing viability and late apoptosis indicated that the increase in the number of late apoptotic cells occurred at the expense of viable cells. The AA-induced toxicity showed considerable variance among donors when analysed by the late apoptosis state (Fig. 4C) . For lymphocyte samples coming from the majority of donors 50% viability/toxicity was calculated at 100-120 mM AA, while for adduct treatment 50% viability was around 210 mM AA<>PSO. Vol. 52 Apoptosis induced by arachidonic acid in human lymphocytes 185 The synergism of the combined treatment was revealed when lymphocyte samples (derived of the same donor) were submitted to the three treatments: by AA alone; by AA followed by UVA radiation (AA->UVA); and by UVA radiation preceding addition of AA (UVA-> AA), as is represented graphically in Fig. 5 .
The UVA irradiation, 6 J/cm 2 , was the same at various treatments. Bars of panel A representing dead cell changes (loss of viability) show that increments are proportional to AA concentration, gaining plateau at 120 mM AA, but considerably higher when irradiation follows AA addition (AA->UVA). In the reverse treatment, when irradiation preceded addition of AA, UVA->AA, the synergy was less evident. Panel B -representing late apoptotic cell increments -showed negative values above 100 mM AA due to a shift of fraction of fragmented apoptotic cells towards a nongated debris subfraction. The synergic changes in late apoptosis after combined treatment (AA-> UVA) were compared with the changes in mitochondrial transmembrane potential by alternate staining with the Anx-V/PI and JC-1 probes of samples from the same donor. Density plots and bivariate analysis of lymphocytes treated and stained with JC-1 are exemplified in Fig. 6 . Upon treatment with 100 mM AA there was a shift to gate R2 comprising cells prevalently with collapsed mitochondria (Fig. 6B) , similar to the apoptotic shift in the cytograms in Fig. 1B . Further bivariate analysis with JC-1 staining in gate 1 and 2 gave pictures shown in panels 6 C, D and E, F, respectively. Regions 3 of panels C and D contained mainly native cells and regions R4 and R6 of panels E and F -cells with partially or completely collapsed mitochondrial potential. Notably, the changes in the numerical values (% of cells) of regions R4 and R6 of gate 2 (R2) were more significant.
The dose relationship of apoptosis (detected by Anx-V/PI) was compared with that of transmembrane potential collapse (detected by JC-1) in Fig. 7 . Bivariate analyses of both markers were compared for treated samples, derived from the same donor, and alternatively labelled with Anx-V/PI or JC-1. This was done to verify whether the mitochondrial collapses were in concordance with apoptosis induced by membrane damage.
The brane collapse proceeds by a different pathway than the outer membrane damage by AA alone.
Characteristics of additives to the cell culture
Absorption spectra
Arachidonic acid has a characteristic absorption spectrum in the region of 260-350 nm, with three peaks at 287, 301, 315 nm and a saddle at 260 nm. The other peak, in the far ultraviolet at 196.5 nm, has an absorption coefficient about 850 times higher than the peak at 301 nm (note the concentrations of the measured samples in Fig. 8) .
The absorption spectrum of the adduct, AA<>PSO, shows a broad band at 252-259 nm; this band was taken for estimation of adduct concentration with a molar absorption coefficient of 6240 at its maximum; the lower band was at 285 nm, with a saddle at 271 nm. Another peak of the compound at 232 nm with a minimum at 240 nm became clearly visible only after separation by HPLC (not shown). Altogether, the absorption spectrum of AA<>PSO resembled that of psoralen mono-adducts to unsaturated fatty acids, as formerly described (Frank et al., 1998; Zarębska et al., 1998) .
Arachidonic acid adduct structure The arachidonic acid adduct structure was established on the basis of its mass spectra and NMR analysis. Mass spectra of the chromatographic isolates with R F 0.49 showed a main peak at average m/z 491.312 (+1), equal to the sum of AA+PSO estimated at 491.648 (+1); this indicated formation of a monoadduct of psoralen and arachidonic acid. Fragmented moieties of the adduct were found: PSO at 187.059 (calculated 187.039) and AA at 305.283 m/z. The NMR data on all additives to the cell culture are presented in Table 1 .
NMR characteristics of the adduct
The proton signals of pyrone ring of adduct, 3H and 4H, moved to the aliphatic part of the spectrum, appearing as signals at cb3.40 m and cb3.69 m (cb, cyclobutane ring). Two vinylene protons out of eight were lost in the acid indicating attachment of one vinylene bond. A shift around 2.89 p.p.m. indicated changes in the internal flanking protons, -CH 2 -, positioned at C 7,10,13 of the intact fatty acid. That signal was decreased to two protons out of six, and a new signal with four protons was shifted upfield to 2.40 p.p.m. Signals of the external flanking protons -CH 2 -of C4 and C16 were slightly shifted upfield at 2.10 m and 2.07 m, respectively, and showed an asymmetric enlargement; a new adjacent signal appeared at cb 2.18 m in vicinity, originating from cyclobutane ring (vinylene ridge). That new cb signal, accompanied by changes in the internal flanking protons of C7 and C10, indicated saturation of the 8==9 vinylene bond. The signals of the adduct appearing between 3.8 and 2.1 p.p.m. were assigned to a cyclobutane ring including the 3-4 bonding of the pyrone ring, and 8-9 of the vinylene bond, and this was further confirmed by TOCSY experiments. TOCSY spectra indicated couplings of attached PSO: 7.65à 6.74à7.26 [5¢Hà4¢Hà8H]. The cyclobutane ring was represented by two patterns of cross-peaks: one at 3.69à3.40à2.45à2. 18 [4Hà3Hà9Hà8H] , and the other at 3.69à 3.40à2.58à2. 18 [4Hà3Hà8Hà9H] .
The changes in the vinylene protons between 5.15-5.55 p.p.m., taken together with multiple peaks of 5H (doublet) and 8H (triplet) of the PSO moiety (see Table 1 ), and two patterns of cross-peaks of the cyclobutane ring indicated that two isomeric forms of the adduct were present in the eluted sample (chromatographic isolate at R F 0.49).
Based on our previous studies on the photochemical attachment of PSO to linoleic acid (Zarębska et al., 1998) , the above data justified the following formula of the adduct AA<>PSO, appearing in two isomeric forms (Fig. 9) . The cyclobutane attachment of PSO to the vinylene bond of AA appears at: C3 PSO -C4  PSO -C8  AA -C9  AA and C4  PSO -C3   PSO   -C8 AA -C9 AA , with the psoralen moiety directed towards AA-head or AA-tail, respectively (Frank et al., 1998) . The chromatographic system applied in our procedure did Vol. 52 Apoptosis induced by arachidonic acid in human lymphocytes 189 All spectra recorded in deuterated chloroform, at 25°C. Signals belonging to a cyclobutane ring are preceded by cb. The psoralen ring protons are numbered with letter H, while arachidonic acid protons are indicated by sole numbers.
not separate the two isomers of the adduct; hence, the leukocytes were treated with a mixture of the two isomers.
DISCUSSION
Toxicity level of AA
In our experiments, AA was estimated to be toxic at 100 -120 mM (average for lymphocytes from eight donors) as was inferred from the late apoptosis response, after 20 h. The toxicity threshold of combined treatment with (AA->UVA) was somewhat lower, below 100 mM AA. In the reverse experiments with UVA radiation preceding addition of AA the synergic action was less evident. This might indicate that under UVA radiation membrane damage is induced by AA photoproducts, additionally to AA alone. Exogeneous AA Exogeneous AA added to cultures of lymphocytes in our experiments only slightly exceeded the concentration of individual fatty acids in the plasma in vivo. In rat plasma AA was estimated to be 30-130 mM in fed animals, and 50-600 mM in exercised, fasted or stressed states (Calder et al., 1991) . Free AA in the plasma of humans, non esterified and unbound to albumins, fluctuated between 5.8 and 49.3 mM as cited by Pompéia et al. (2002) . Those author's findings indicate that exogenously added and internalised AA is incorporated into phospholipids prior to inducing DNA fragmentation and a cascade of apoptosis.
Variation in viability/toxicity
The effect of AA upon primary leukocytes from healthy donors was not uniform. The variation of values in 50% viability of lymphocytes (100 to 120 mM AA) reported here probably reflects the presence of various fractions of cells with different sensitivities to AA. The study of Pompéia and coworkers (2002) on neoplastic cell lines in culture at 5´10 5 cells/ml showed 50% viability in the range of 82-116 mM AA. Interestingly, primary lymphocytes were shown to be more sensitive than Jurkat lymphoma cells to a combined drug and UVA treatments in the presence of 8-MOP, CPZ and TMA (see Wolnicka-Głubisz et al., 2002) .
Photoadduct of AA
The approximately twice lower effect of the photoadduct, AA<>PSO, than of free AA may stem from the difference in their lipophilic affinity and limited transport inside the cell. Oxygenated forms of AA or of its adduct AA<>PSO may additionally contribute to the apoptotic pathway(s) initiated in lipids. With a sensitive gas chromatography-MS assay, it was possible to detect 5-hydroxyeicosatetraenoic acid (5-HETE) in plasma of patients submitted to PUVA (8-MOP+UVA), which compound constituted 80% of all HETE isomers (Wiswedel et al., 2000) .
Plasma membrane damage and apoptosis Accumulating evidence suggests that in addition to the apoptosis triggered by damage to nuclear DNA, damage to the cell membranes play a role in induction of apoptosis. Although our studies do not elucidate a direct link between reactions in the plasma membrane and apoptosis or the collapse of the The adduct formula was based on NMR and MS analyses, for details see text and data of Table 1. transmembrane potential of lymphocytesone can visualize two directions for future studies, discussed below: 1st -release of AA from phospholipids due to the combined action of UVA radiation and psoralen; 2nd -UV-irradiated phosphatidylcholine may be transformed into a derivative of platelet-activating factor (PAF), a molecular sensor for cellular damage, which may act as a PAF-like receptor agonist.
Release of AA by activation of a phospholipase (PLA2) pathway following UVA radiation has been shown in mouse fibroblasts. Irradiation by UVA (2.5-10 J/cm 2 ) activated PLA2 which in turn induced the release of [ 3 H]-AA from cell lysates into the medium (Cohen & De Leo, 1993) . The peak of AA release was noted 4 hours after irradiation, which supported the idea of PLA2 activation by UVA action. The release of [ 14 C]-AA from a culture of human keratinocytes (NCTC 2544) was observed at a dose as low as 2.5 J/cm 2 of UVA; AA released to the medium effected cell death, detectable by trypan blue (TB) test; the TB + cell number increased after 24 h in comparison with 0.5 h after irradiation (Punnonen et al., 1991) . There is still a matter of debate whether cell membrane damage or mitochondrial damage are the causative agents for apoptosis induction upon AA treatment. Our preliminary studies indicate that both targets are involved. The mechanism of apoptosis studied in clonal hepatoma rat cells showed that arachidonic acid released by PLA2 activation triggered apoptosis through the mitochondrial pathway (Penzo et al., 2004) . Jurkat cells treated in serum free medium by PUVA (50 mM PSO + 1.8 J/cm 2 ) and by irradiated psoralen alone, also indicated mitochondrial membrane collapse as responsible for apoptosis (Canton et al., 2002) . However, in our investigations the cells were treated with AA and PSO additives in medium containing 5% calf serum, aiming to be closer to the conditions in vivo (Pompéia et al., 2002) . Apoptosis inducing a signal transduction pathway alternatively to the mitochondrial pathway may be considered. Recently, it has been shown in studies on mice that UV-induced platelet-activating factor (PAF) activates cytokine synthesis and initiates UV-induced immune suppression . A phospholipid proinflammatory mediator that participates in the PUVA-induced immunosuppression was inferred from ex vivo UV-irradiated phosphatidylcholine (by means of 270-390 nm emitting lamps), and then injected into mice . It was further postulated that the PAF pathway may be involved in PUVA-induced immune suppression (Wolf et al., 2003, unpublished data) .
Our findings, showing an enhanced effect of cell damage after addition of (AA+PSO) and UVA, support the concept that PUVA-induced apoptosis may be initiated by release of AA from lymphocyte phospholipids. In turn, released AA becomes an apoptogenic agent towards adjacent cells. Undoubtedly, the concept of apoptosis induced by a signaling pathway through the cell membrane damage requires further studies.
The in vivo metabolism of arachidonic acid, relevant to this investigation, was a subject of intensive research (Wolf & Laster, 1999) . AA and its metabolites, the leukotrienes LTB4 and LTD4, were considered to be cellular toxins in neuronal apoptosis in HIV disease; culturing HIV-1 infected monocytes with glia cells stimulated the synthesis of AA and its metabolites, LTB4, LTD4, and PAF, leading to injury of neurons present in the culture. An increased release of AA was postulated to be induced by activated PLA2 (Nath, 2001) . It was found that AA converts glutathione depletion-induced apoptosis to necrosis by promoting lipid peroxidation and reducing caspase-3 activity in rat glioma cells (Higuchi & Yoshimoto, 2002) . AA-induced apoptosis was connected with oxidative stress accompanied by glutathione depletion (Vento et al., 2000) .
All the data discussed above suggest that whatever the cause of AA release to the medium, the released AA combined with UVA radiation contributes to apoptosis triggered in cell membranes. The synergic action of AA and UVA radiation suggests that besides free AA, arachidonic acid photoproducts also induce apoptosis.
In conclusion, our findings establish that treatment with arachidonic acid and psoralen combined with UVA radiation contribute to lymphocyte induced apoptosis. These model experiments are relevant to the mechanism of PUVA action in the human organism.
